Peer-reviewedCC BY-NC-ND 4.0Scientific Reports
Metabolomics-based central obesity identifies subtypes musculoskeletal disorders management
Related
- Changes in Gait Speed During a 12-Month Multidisciplinary Obesity Management Program Including Semaglutide: A Real-World Observational Study in Japanese Adults With Musculoskeletal Disorders
- Metabolically Unhealthy Obesity: Novel Subtypes Defined by Integrated Metabolomics and Hematology
- Machine learning clustering of multidimensional clinical features identifies four prognostically distinct sepsis subtypes
- Proteomics characterization of muscle-invasive bladder carcinoma identifies molecular subtypes and subtype-specific biological processes
- Musculoskeletal disorders and ergonomic risk factors among petrochemical control room operators with health promotion and intervention strategies
BibTeX
@article{han2026metabolomicsbased,
title = {{Metabolomics-based central obesity identifies subtypes musculoskeletal disorders management}},
author = {Qiong Han and Yue Zhang and Jing Feng and Bei Zhou and Chunyan Yin and Jinyi Wu},
journal = {Scientific Reports},
year = {2026},
month = nov,
doi = {10.1038/s41598-026-65080-9},
url = {https://www.nature.com/articles/s41598-026-65080-9},
note = {CC BY-NC-ND 4.0},
}
RIS
TY - JOUR
TI - Metabolomics-based central obesity identifies subtypes musculoskeletal disorders management
AU - Qiong Han
AU - Yue Zhang
AU - Jing Feng
AU - Bei Zhou
AU - Chunyan Yin
AU - Jinyi Wu
PY - 2026
DA - 2026/11/02
JO - Scientific Reports
DO - 10.1038/s41598-026-65080-9
UR - https://www.nature.com/articles/s41598-026-65080-9
SN - 2045-2322
ER -